NOVN.CH
95.62
+0.19%↑
ALC
92.24
+0.55%↑
LONN.CH
542.6
-1.24%↓
SOON.CH
319
-0.78%↓
NOVN.CH
95.62
+0.19%↑
ALC
92.24
+0.55%↑
LONN.CH
542.6
-1.24%↓
SOON.CH
319
-0.78%↓
NOVN.CH
95.62
+0.19%↑
ALC
92.24
+0.55%↑
LONN.CH
542.6
-1.24%↓
SOON.CH
319
-0.78%↓
NOVN.CH
95.62
+0.19%↑
ALC
92.24
+0.55%↑
LONN.CH
542.6
-1.24%↓
SOON.CH
319
-0.78%↓
NOVN.CH
95.62
+0.19%↑
ALC
92.24
+0.55%↑
LONN.CH
542.6
-1.24%↓
SOON.CH
319
-0.78%↓
Overview
Share price change
24h
Current
Min
292.2
Max
299.6
News Sentiment
By Acuity
50%
50%
167 / 390 Healthcare
Roche Holding AG Chart
Past performance is not a reliable indicator of future results.
Related News
23 Oct 2024, 05:38 UTC
Roche Increases Dividend on Higher Sales
DJ
Read
30 Sept 2024, 05:44 UTC
Regor to Sell Breast Cancer CDK Inhibitors to Roche Unit for Upfront $850 Million
DJ
Read
12 Sept 2024, 09:29 UTC
Roche Shares Slump on Oral Weight-Loss Drug Candidate Side Effects
DJ
Read
7 Aug 2024, 07:03 UTC
Roche Weighs Divestment of Cancer Data Startup, FT Reports
DJ
Read
5 Aug 2024, 22:43 UTC
Poseida Rises After Reporting Smaller-Than-Seen Loss, Partnership Progress
DJ
Read
29 Oct 2024, 21:31 UTC
AbbVie's Deal for Alzheimer's Antibody Raises Curtain for Roche News on Wednesday -- Barrons.com
DJ
Read
23 Oct 2024, 08:57 UTC
Roche's Pharma Growth Drivers Deliver -- Market Talk
DJ
Read
23 Oct 2024, 08:10 UTC
Roche's Backed Outlook Could Drive Consensus Downgrades on Adverse Currency Effects -- Market Talk
DJ
Read
23 Oct 2024, 07:02 UTC
Roche Posts Solid Results On Better-Than-Expected Key Drugs Performance -- Market Talk
DJ
Read
23 Oct 2024, 05:03 UTC
Roche 3Q Sales Rose 9%
DJ
Read
23 Oct 2024, 05:02 UTC
Roche to Further Increase Dividend
DJ
Read
23 Oct 2024, 05:01 UTC
Roche Had Seen 2024 Sales Growth In Mid-Single-Digits
DJ
Read
23 Oct 2024, 05:01 UTC
Roche Had Seen Core EPS Growth In High Single-Digits
DJ
Read
23 Oct 2024, 05:01 UTC
Roche Backs 2024 View
DJ
Read
23 Oct 2024, 05:01 UTC
Roche 9-Mos Sales CHF44.98B
DJ
Read
1 Oct 2024, 14:47 UTC
Lonza Announced Acquisition on March 20
DJ
Read
1 Oct 2024, 14:46 UTC
Lonza Has Bought Manufacturing Site in California From Roche for $1.2B
DJ
Read
1 Oct 2024, 14:45 UTC
Lonza Completes Acquisition of Biologics Site in Vacaville (US) From Roche
DJ
Read
1 Oct 2024, 09:54 UTC
Roche's Pharma Strategy Reflects Confident Pipeline Outlook -- Market Talk
DJ
Read
1 Oct 2024, 07:04 UTC
Roche's Pharma Strategy Signals Obesity Push -- Market Talk
DJ
Read
1 Oct 2024, 06:06 UTC
Roche's Sharpened R&D Focus, Cost Discipline Should Clear Productivity Concerns -- Market Talk
DJ
Read
30 Sept 2024, 11:21 UTC
Roche's Giredestrant Gains Combination Potential With Regor's CDK Inhibitor Deal -- Market Talk
DJ
Read
30 Sept 2024, 05:29 UTC
Regor to Sell Breast Cancer CDK Inhibitors to Roche Unit for Upfront $850 Mln
DJ
Read
30 Sept 2024, 05:16 UTC
Regor: Sale Expected to Close 4Q, Subject to Conditions
DJ
Read
30 Sept 2024, 05:15 UTC
Regor Also Eligible to Get More Cash Payments Based on Certain Milestones
DJ
Read
30 Sept 2024, 05:15 UTC
Regor to Get $850 Mln Upfront Payment From Sale
DJ
Read
30 Sept 2024, 05:14 UTC
Regor to Sell Portfolio of Breast Cancer Treatment CDK Inhibitors to Roche
DJ
Read
30 Sept 2024, 05:14 UTC
Regor Selling Inhibitors to Roche Unit Genentech
DJ
Read
19 Aug 2024, 20:01 UTC
IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter -- IBD
DJ
Read
7 Aug 2024, 14:22 UTC
It Isn't Time to Worry About Wegovy Yet -- Heard on the Street -- WSJ
DJ
Read
Peer Comparison
Price change
Roche Holding AG Forecast
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
$
